Stock 300110 HUAREN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Huaren Pharmaceutical Co., Ltd.

Equities

300110

CNE100000SW1

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 19/05/2024 BST 		5-day change 1st Jan Change
3.6 CNY -0.28% Intraday chart for Huaren Pharmaceutical Co., Ltd. -3.23% -14.69%
04-24 Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Huaren Pharmaceutical CO.,LTD is a China-based company principally engaged in the research, development, manufacture and distribution of non polyvinyl chloride (PVC) soft bag large volume preparations. The Company provides basic infusion products, including sodium chloride infusions, dextrose infusions and compound sodium chloride infusions, among others; infusion products for treatment, including metronidazole and sodium chloride infusions, ciprofloxacin lactate and sodium chloride infusions and others, as well as nutritious infusion products, among others. The Company distributes its products in domestic market, with Northeast China as its main market.

Number of employees: 2,681

Sales per Business

CNY in Million2022Weight2023Weight Delta
Basic Infusion
50.0 %
734 45.3 % 819 50.0 % +11.58%
Peritoneal Dialysis Fluid
20.8 %
276 17.0 % 340 20.8 % +23.45%
Other
19.1 %
382 23.6 % 312 19.1 % -18.34%
Therapeutic Preparation
10.1 %
185 11.4 % 165 10.1 % -10.41%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,619 100.0 % 1,636 100.0 % +1.04%

Managers

Managers TitleAgeSince
Liang Hong CEO
 Chief Executive Officer 53 28/12/22
Li Ping Han DFI
 Director of Finance/CFO 39 25/10/20
Xiao Dong Yang CHM
 Chairman 56 18/07/19
Wen Tao Yan IRC
 Investor Relations Contact - -
Cong Wu SEC
 Corporate Secretary 44 22/12/16

Members of the board

Members of the board TitleAgeSince
Xiang Dong Ji BRD
 Director/Board Member 50 11/11/18
Gen Fu Feng BRD
 Director/Board Member 67 27/08/19
Tian Xi Zhang BRD
 Director/Board Member 67 27/08/19
Li Qiang CHM
 Chairman 63 05/08/19
Yang Li BRD
 Director/Board Member 44 05/08/19
Xiao Dong Yang CHM
 Chairman 56 18/07/19
Chuan Wen Dong BRD
 Director/Board Member 39 20/04/22
Su Bin Zhu BRD
 Director/Board Member 50 20/04/22
Xuan Zhang BRD
 Director/Board Member 49 05/08/19
Jun Wei Song BRD
 Director/Board Member 51 15/01/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,182,212,982 647,587,618 ( 54.78 %) 0 54.78 %

Shareholders

NameEquities%Valuation
Xiao Dong Yang
0.1143 %
1,120,000 0.1143 % 572 253 ¥
Wanjia Asset Management Co., Ltd.
0.0712 %
697,400 0.0712 % 356 330 ¥
GF Fund Management Co., Ltd.
0.0521 %
510,800 0.0521 % 260 988 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.0232 %
226,800 0.0232 % 115 881 ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.0178 %
174,800 0.0178 % 89 312 ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
0.007636 %
74,800 0.007636 % 38 218 ¥
Manulife TEDA Fund Management Co., Ltd.
0.000694 %
6,800 0.000694 % 3 474 ¥

Company contact information

Huaren Pharmaceutical Co., Ltd.

187 Zhuzhou Road Hi-tech Industrial Park

266101, Qingdao

+

http://www.qdhuaren.com
address Huaren Pharmaceutical Co., Ltd.(300110)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sector Generic Pharmaceuticals

1st Jan change Capi.
HUAREN PHARMACEUTICAL CO., LTD. Stock Huaren Pharmaceutical Co., Ltd.
-14.69% 588M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+22.35% 44.12B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+22.22% 22.61B
SANDOZ GROUP AG Stock Sandoz Group AG
+17.04% 15.11B
CIPLA LIMITED Stock Cipla Limited
+15.73% 13.61B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+57.91% 13.34B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.98% 6.94B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+15.65% 5.75B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300110 Stock
  4. Company Huaren Pharmaceutical Co., Ltd.